HRT Financial’s Editas Medicine EDIT Stock Holding History

HRT Financial’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35K	Buy	+14,515	New	+$30.7K	﹤0.01%	3508
2024 Q4	–	Sell	-448,297	Closed	-$1.53M	–	2595
2024 Q3	$1.53M	Buy	448,297 +150,267	+50%	+$654K	0.01%	1006
2024 Q2	$1.39M	Buy	+298,030	New	+$1.68M	0.01%	865
2024 Q1	–	Sell	-143,401	Closed	-$1.45M	–	2493
2023 Q4	$1.45M	Buy	143,401 +130,049	+974%	+$1.14M	0.01%	805
2023 Q3	$104K	Buy	+13,352	New	+$114K	﹤0.01%	1944
2022 Q4	–	Sell	-164,713	Closed	-$2.02M	–	2619
2022 Q3	$2.02M	Buy	+164,713	New	+$2.57M	0.02%	598
2022 Q1	–	Sell	-32,537	Closed	-$863K	–	3277
2021 Q4	$863K	Buy	+32,537	New	+$1.12M	0.01%	1258

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's EDIT Position: Q1 2026 in Review

HRT Financial opened a new position in Editas Medicine (EDIT) in Q1 2026: 14,515 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #3508 among its holdings. This is a return to the name: HRT Financial previously reported a position in EDIT as recently as Q3 2024.

HRT Financial first reported a position in EDIT in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.02M in Q3 2022. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

HRT Financial held 14,515 shares of Editas Medicine worth $35K as of Q1 2026.
Editas Medicine was a new HRT Financial position in Q1 2026.
Editas Medicine made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3508 holding.
HRT Financial first reported a position in Editas Medicine in Q4 2021 and has held it in 7 quarters since.
HRT Financial's Editas Medicine position peaked at $2.02M in Q3 2022.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.